News for Healthier Living

Study Suggests Higher Risk of CV Events When Initiating Denosumab for Osteoporosis in Dialysis Patients

An observational study emulated a target trial to determine the risk for major adverse cardiovascular events (MACE) and fracture prevention effects with denosumab versus bisphosphonates in dialysis-dependent patients.

January 6, 2025


January 8 2025

January 7 2025

January 6 2025

January 4 2025

January 3 2025

January 2 2025

January 1 2025

December 31 2024

December 30 2024

December 29 2024

December 28 2024

December 27 2024

December 26 2024